EP0659192A4 - Novel antibodies for conferring passive immunity against infection by a pathogen in humans. - Google Patents
Novel antibodies for conferring passive immunity against infection by a pathogen in humans.Info
- Publication number
- EP0659192A4 EP0659192A4 EP93921412A EP93921412A EP0659192A4 EP 0659192 A4 EP0659192 A4 EP 0659192A4 EP 93921412 A EP93921412 A EP 93921412A EP 93921412 A EP93921412 A EP 93921412A EP 0659192 A4 EP0659192 A4 EP 0659192A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- pathogen
- humans
- immunity against
- against infection
- passive immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000036039 immunity Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 230000001717 pathogenic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94165492A | 1992-09-09 | 1992-09-09 | |
US941654 | 1992-09-09 | ||
PCT/US1993/008435 WO1994005690A1 (en) | 1992-09-09 | 1993-09-08 | Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0659192A1 EP0659192A1 (en) | 1995-06-28 |
EP0659192A4 true EP0659192A4 (en) | 1996-09-11 |
Family
ID=25476840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93921412A Withdrawn EP0659192A4 (en) | 1992-09-09 | 1993-09-08 | Novel antibodies for conferring passive immunity against infection by a pathogen in humans. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0659192A4 (en) |
JP (1) | JPH08500979A (en) |
KR (1) | KR950703573A (en) |
CN (1) | CN1087681A (en) |
AU (1) | AU4851193A (en) |
CA (1) | CA2143417A1 (en) |
NZ (1) | NZ256232A (en) |
WO (1) | WO1994005690A1 (en) |
ZA (1) | ZA936260B (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0782626A1 (en) * | 1994-09-19 | 1997-07-09 | Rijkslandbouwuniversiteit Wageningen | Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogens in crops |
SE9500148D0 (en) * | 1995-01-18 | 1995-01-18 | Bioinvent Internatioal Ab | Antibodies for use in cancer therapy and diagnosis |
AUPP221098A0 (en) | 1998-03-06 | 1998-04-02 | Diatech Pty Ltd | V-like domain binding molecules |
US6455677B1 (en) | 1998-04-30 | 2002-09-24 | Boehringer Ingelheim International Gmbh | FAPα-specific antibody with improved producibility |
EP0953639A1 (en) * | 1998-04-30 | 1999-11-03 | Boehringer Ingelheim International GmbH | FAPalpha-specific antibody with improved producibility |
US7829084B2 (en) | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
AU2002241922B2 (en) * | 2001-01-17 | 2007-10-25 | Aptevo Research And Development Llc | Binding domain-immunoglobulin fusion proteins |
AU2008200400B2 (en) * | 2001-01-17 | 2012-06-07 | Aptevo Research And Development Llc | Binding domain-immunoglobulin fusion proteins |
AU2002256985B8 (en) * | 2001-01-26 | 2008-03-20 | Inhibitex, Inc | Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections |
JP4794301B2 (en) | 2003-06-11 | 2011-10-19 | 中外製薬株式会社 | Antibody production method |
US7754209B2 (en) | 2003-07-26 | 2010-07-13 | Trubion Pharmaceuticals | Binding constructs and methods for use thereof |
TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
US10011858B2 (en) * | 2005-03-31 | 2018-07-03 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
TW200722518A (en) | 2005-03-31 | 2007-06-16 | Chugai Pharmaceutical Co Ltd | Sc(fv)2 structural isomers |
JP5085322B2 (en) | 2005-06-10 | 2012-11-28 | 中外製薬株式会社 | Pharmaceutical composition containing sc (Fv) 2 |
JP5068167B2 (en) | 2005-06-10 | 2012-11-07 | 中外製薬株式会社 | Stabilizer for protein preparation containing meglumine and use thereof |
DK1912675T3 (en) | 2005-07-25 | 2014-03-24 | Emergent Product Dev Seattle | B-cell reduction using specific and cd37-cd20-specific binding molecules |
ES2654040T3 (en) | 2006-03-31 | 2018-02-12 | Chugai Seiyaku Kabushiki Kaisha | Antibody modification method for the purification of bispecific antibodies |
DK3056568T3 (en) | 2006-03-31 | 2021-11-01 | Chugai Pharmaceutical Co Ltd | PROCEDURES FOR CONTROL OF THE BLOOD PHARMACOKINETICS OF ANTIBODIES |
JP2009539413A (en) | 2006-06-12 | 2009-11-19 | トゥルビオン・ファーマシューティカルズ・インコーポレーテッド | Single-chain multivalent binding protein with effector function |
CN106519025B (en) | 2007-09-26 | 2021-04-23 | 中外制药株式会社 | Method for changing isoelectric point of antibody by using amino acid substitution of CDR |
CL2008002886A1 (en) | 2007-09-26 | 2009-12-04 | Chugai Pharmaceutical Co Ltd | Constant region of a human antibody; anti-interleukin-6 (yl-6) receptor antibody and pharmaceutical composition comprising it. |
ES2368700T3 (en) | 2008-04-11 | 2011-11-21 | Emergent Product Development Seattle, Llc | IMMUNOTHERAPEUTIC AGENT FOR CD37 AND COMBINATION WITH A BIFUNCTIONAL CHEMOTHERAPEUTIC AGENT OF THE SAME. |
JP5787446B2 (en) | 2009-03-19 | 2015-09-30 | 中外製薬株式会社 | Antibody constant region variants |
WO2010107110A1 (en) | 2009-03-19 | 2010-09-23 | 中外製薬株式会社 | Antibody constant region variant |
EP2473530B1 (en) * | 2009-09-03 | 2015-04-22 | Vancouver Biotech Ltd. | Monoclonal antibodies against gonadotropin-releasing hormone receptor |
WO2011037158A1 (en) | 2009-09-24 | 2011-03-31 | 中外製薬株式会社 | Modified antibody constant regions |
US10435458B2 (en) | 2010-03-04 | 2019-10-08 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variants with reduced Fcgammar binding |
TR201802772T4 (en) | 2010-11-17 | 2018-03-21 | Chugai Pharmaceutical Co Ltd | Multi-specific antigen binding molecule with alternative function for the function of blood coagulation factor VIII. |
CN109134658B (en) | 2011-10-31 | 2022-10-14 | 中外制药株式会社 | Antigen binding molecules that control association of heavy and light chains |
KR102353885B1 (en) | 2013-03-13 | 2022-01-20 | 이미지냅 인코포레이티드 | Antigen binding constructs to cd8 |
BR112016006197B1 (en) | 2013-09-27 | 2023-04-11 | Chugai Seiyaku Kabushiki Kaisha | METHOD FOR PRODUCING A BISPECIFIC POLYPEPTIDE ANTIBODY |
FR3025517B1 (en) | 2014-09-10 | 2016-12-23 | Repropharm | LIGANDS POTENTIATING THE BIOACTIVITY OF GONADOTROPHINS |
MA40764A (en) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | THERAPEUTIC AGENT INDUCING CYTOTOXICITY |
EP3279216A4 (en) | 2015-04-01 | 2019-06-19 | Chugai Seiyaku Kabushiki Kaisha | Method for producing polypeptide hetero-oligomer |
NZ739721A (en) | 2015-08-07 | 2019-09-27 | Imaginab Inc | Antigen binding constructs to target molecules |
EP3352760A4 (en) | 2015-09-21 | 2019-03-06 | Aptevo Research and Development LLC | Cd3 binding polypeptides |
WO2017115773A1 (en) | 2015-12-28 | 2017-07-06 | 中外製薬株式会社 | Method for promoting efficiency of purification of fc region-containing polypeptide |
TW202342540A (en) | 2016-03-14 | 2023-11-01 | 日商中外製藥股份有限公司 | Cell injury inducing therapeutic drug for use in cancer therapy |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4632909A (en) * | 1983-10-31 | 1986-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies which block infectivity of malarial parasites to mosquitoes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63267295A (en) * | 1986-12-03 | 1988-11-04 | Sumitomo Chem Co Ltd | Human antibody, antibody gene and corresponding recombinant |
-
1993
- 1993-08-26 ZA ZA936260A patent/ZA936260B/en unknown
- 1993-09-08 WO PCT/US1993/008435 patent/WO1994005690A1/en not_active Application Discontinuation
- 1993-09-08 AU AU48511/93A patent/AU4851193A/en not_active Abandoned
- 1993-09-08 JP JP6507519A patent/JPH08500979A/en active Pending
- 1993-09-08 EP EP93921412A patent/EP0659192A4/en not_active Withdrawn
- 1993-09-08 CA CA002143417A patent/CA2143417A1/en not_active Abandoned
- 1993-09-08 NZ NZ256232A patent/NZ256232A/en unknown
- 1993-09-09 CN CN93119080A patent/CN1087681A/en active Pending
-
1995
- 1995-03-09 KR KR1019950700936A patent/KR950703573A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4632909A (en) * | 1983-10-31 | 1986-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies which block infectivity of malarial parasites to mosquitoes |
Non-Patent Citations (3)
Title |
---|
D. SYLVESTER ET AL.: "Construction and in-vitro characterization of a humanized monoclonal antibody against Plasmodium falciparum sporozoites.", THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, vol. 47, no. 4 suppl., October 1992 (1992-10-01), LAWRENCE, USA, pages 233, XP002007068 * |
L. RIECHMANN ET AL.: "Reshaping human antibodies for therapy.", NATURE, vol. 332, 24 March 1988 (1988-03-24), LONDON, GB, pages 323 - 327, XP002007067 * |
See also references of WO9405690A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPH08500979A (en) | 1996-02-06 |
KR950703573A (en) | 1995-09-20 |
WO1994005690A1 (en) | 1994-03-17 |
CA2143417A1 (en) | 1994-03-17 |
AU4851193A (en) | 1994-03-29 |
EP0659192A1 (en) | 1995-06-28 |
CN1087681A (en) | 1994-06-08 |
NZ256232A (en) | 1997-02-24 |
ZA936260B (en) | 1994-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0659192A4 (en) | Novel antibodies for conferring passive immunity against infection by a pathogen in humans. | |
SG47458A1 (en) | Cyclically varying elevator grouping | |
DE69205781T2 (en) | Parallel gripper device. | |
GB9305577D0 (en) | Inductive sensors | |
GB2263318B (en) | Device for reciprocating a plunger or the like | |
EP0598919A4 (en) | Shock sensor. | |
GB9110698D0 (en) | Inductive displacement sensors | |
GB9206203D0 (en) | Inductive sensors | |
GB9123585D0 (en) | Silicon neuron | |
DE59308475D1 (en) | INDUCTIVE SENSOR | |
GB2250612B (en) | Stroke control device | |
DE69431785D1 (en) | NOISE-ABSORBING DEVICE | |
GB2281126B (en) | Semiconductor capacitive acceleration sensor | |
IT1241383B (en) | CONTROL DEVICE FOR A VEHICLE LOCK | |
GB9014332D0 (en) | Sucker device | |
IT9083405A0 (en) | TEXTILE PACKAGE PALLETIZATION PROCEDURE. | |
ITTO910212A1 (en) | TIRE FORMING DEVICE | |
GB9211116D0 (en) | Inductive sensor | |
GB9025142D0 (en) | Intelligent vibration sensor | |
GB2296977B (en) | Semi-conductor acceleration sensor | |
ZA949920B (en) | Specific hyperimmune anti-hiv globulin for passive immunization | |
KR950022557U (en) | Bag shoulder | |
IL127163A0 (en) | A vaccine which provides protective immunity against a bacterial pathogen | |
EP0597514A3 (en) | A vertical PMP semiconductor device. | |
BR9101996A (en) | VACUUM-ACTIVATED ANTI-LOCKING SYSTEM, ELECTRONICALLY CONTROLLED |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950324 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched | ||
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19970402 |